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A review of current strategies to reduce intraoperative
bacterial contamination of surgical wounds
ÜbersichtübergegenwärtigeStrategienzurReduktionderintraoperativen
bakteriellen Kontamination von Op-Wunden
Abstract
Surgical site infections are a mean topic in cardiac surgery, leading to
a prolonged hospitalization, and substantially increased morbidity and
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mortality. One source of pathogens is the endogenous flora of the pa-
tient’s skin, which can contaminate the surgical site. A number of pre-
operative skin care strategies are performed to reduce bacterial con- 1 Department of
Cardiovascular Surgery, tamination like preoperative antiseptic showering, hair removal, anti-
Charité Hospital, Medical
University, Berlin, Germany
sepsis of the skin, adhesive barrier drapes, and antimicrobial prophy-
laxis. Furthermore we can also support the natural host defense by
optimal intra-operative management of oxygen supply, normoglycemia,
and temperature. Nevertheless we still have a number of patients, who
develop a surgical site infection. Therefore new skin care strategies are
introduced to reduce the contamination by the endogenous skin flora.
We present the use of a new microbial sealant, InteguSeal
®, which was
evaluatedinpatientsundergoingcardiacsurgery.Thepreliminaryresults
of this investigation showed a trend in surgical site infection reduction
by the use of this new microbial sealant.
Keywords: skin bacteria, antibiotic prophylaxis, antibiotic resistance,
microbial sealant, surgical site infections
Zusammenfassung
DiePräventionpostoperativerWundinfektionenisteinwichtigesAnliegen
in der Herzchirurgie, weil diese mit erhöhter Morbidität, Mortalität und
verlängerterKrankenhausverweildauerverbundensind.Einegesicherte
Infektionsquelle ist die residente Hautflora des Patienten, die die Op-
Wunde kontaminieren kann. Deshalb wird eine Reihe präoperativer
Maßnahmen zur Reduktion der Hautflora durchgeführt wie antisepti-
sches Ganzkörperduschen, Haarentfernung, Hautantiseptik, Inzisions-
folienundAntibiotikaprophylaxe.WeiterhinkanndienatürlicheWirtsab-
wehr durch optimale intraoperative Sauerstoffversorgung, adäquate
EinstellungdesBlutglukosespiegelsundGewährleistungderNormother-
mie für die Op-Dauer unterstützt werden. Weil trotzdem postoperative
Wundinfektionenauftretenkönnen,werdenneueStrategienzurVermei-
dung der intraoperativen Kontamination durch die Hautflora benötigt.
Hierfür wurde als neue aussichtsreiche Möglichkeit InteguSeal
® entwi-
ckelt und die Effektivität dieser Versiegelungsmethode im Bereich der
Hautdurchtrennung bei Patienten mit herzchirurgischen Operationen
untersucht. Die vorläufigen Ergebnisse zeigen den Trend einer Reduk-
tion der Rate postoperativer Wundinfektionen.
Schlüsselwörter: Hautbakterien, antibiotische Prophylaxe,
Antibiotikaresistenz, mikrobielle Abdichtung, postoperative
Wundinfektion
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Surgical site infections (SSIs) are serious complications
among cardiac surgery. The prevalence of SSIs has been
reported to range from 1.3 to 12.8% [1], [2], [3], [4],
leading to a prolonged hospitalization, and substantially
increased morbidity and mortality. Generally during a
cardiac surgical procedure, the skin needs to be incised
and the exposed tissues are at risk for contamination by
the endogenous skin flora; usually aerobic gram-positive
microbes [5].
Due to the increase complexity of surgical procedures
whichareperformedandtheincreasenumberofpatients
with a serious co-morbidity, the risk of SSIs increases.
Therefore, new strategies within daily cardiac surgery
practices need to be evaluated.
Pathogenesis of surgical site
infection
FormostSSIs,thesourceofpathogensistheendogenous
flora of the patient’s skin [6], [7]. As long as the skin is
intact,itresistmicrobialinvasionduetorelativedryness,
cell mediated immunity and antibody production from T-
lymphocytes [8]. Therefore, microbial contamination of
thesurgicalsiteisanecessaryprecursortodevelopSSIs,
however not every contaminated wound will finally result
in an infected wound. The risk of SSIs conceptualized
according to the following relationship. On the one hand
side there is the amount of inoculated and virulence of
bacteria.Ontheotherhandsidewehavethenaturalhost
defense due to the innate immune system to eliminate
bacteria.Asurgicalsiteinfectionwillnormallyoccurwhen
the contamination of pathogens overcome the host de-
fense system. Quantitatively, 10
5 microorganisms per
gram of tissue will be needed to increase markedly the
probability to develop a SSIs [9].
Reduction of bacterial
contamination of the surgical site
Preoperative management
A number of preoperative skin care strategies will be re-
viewed to reduce the risk for contamination by endogen-
ous skin flora at the surgical site.
Preoperative antiseptic showering
A preoperative antiseptic shower or bath decreases skin
microbialcolonycounts.Garibaldiperformedastudywith
more than 700 patients, using different preoperative
antiseptic showers [10]. Chlorhexidine reduces the bac-
terial colony counts 9.0-fold, while povidine-iodine or tri-
carban-medicated soap reduced colony counts at the
skin only 1.3- and 1.9-fold, respectively. These positive
resultsofreducingtheskin’smicrobialcolonycountsdue
to preoperative showering have no significant influence
on incidence of SSIs rates [11], [12], [13].
Hair removal
Body hair has been though to be a potential carrier of
pathogens and therefore it should be removed from the
surgical site. There are different methods to remove hair
such as shaving with a razor, using an electrical clipper;
or applying a depilatory cream. A number of clinical trials
compared various combinations of these preparatory
techniques.Ingeneral,depilatorycreamusagewasmost
favorable to reduce the risk of SSI [14], [15].
Althoughtheuseofdepilatorieshasbeenassociatedwith
a lower risk of SSI than shaving or clipping, sometimes
patients suffer from hypersensitivity reactions [16].
Seropian showed in the same study that SSI rates were
as high as 5.6% in patients shaved by a razor compared
with the use of depilatory creams 0.6%. The reason for
this increased SSI risk could be due to the produced mi-
croscopiccuts,thatlatercouldserveasafociforbacterial
multiplication [17].
Anotherimportantissueisthetimingtoperformshaving.
During an emergency procedure, the razor, ideally by us-
ing an electrical clipper, will be performed immediately
before surgery will be started. During an elective proce-
dure, however clipping hair immediately before an oper-
ation has been associated with a lower risk for SSIs,
rather than clipping the night before the operation, re-
spectively 1.8% versus 4.0% [18].
Other studies however suggested that independent to
the shaving method, hair removal was associated with
increased SSIs compared to no hair removal [19].
Therefore it is still difficult to make final comments on
the topic hair removal.
Antisepsis of the patient skin
Antisepsis of the skin is an important issue to reduce the
concentrations of bacteria at the operative site. Lilly et
al. [20] showed a progressive reduction due to the “two-
phase”antisepsisasanappropriatemethodforachieving
a higher degree of antisepsis of operation sites. Due to
repeated antisepsis of the skin a further mean reduction
of 90% or more in the yield of bacteria could be shown.
This means that by the use of antiseptic preparations
one can reduce in yield of resident flora to a low equili-
brium level, however complete decontamination will
never occur.
Kampf et al. [21] showed that the best antimicrobial ef-
ficacy could be achieved with alcohol based antiseptic
solutions.Ethanolathigherconcentrations,70%,showed
tobethemosteffectivetreatmentagainstnakedviruses,
whereas propan-1-ol was more effective against the
residentbacterialskinflora.Thecombinationofalcohols
is suggested to have a synergistic effect. The promotion
ofalcohol-basedantisepsis,containingemollients,isalso
a strategy to reduce skin damage and irritation.
2/7 GMS Krankenhaushygiene Interdisziplinär 2007, Vol. 2(2), ISSN 1863-5245
Dohmen et al.: A review of current strategies to reduce intraoperative ...However, the golden rule for the use of antiseptic solu-
tions is that an antiseptic solution can not be effective
unless it will completely dries.
Adhesive barrier drapes
Antisepticsolutionscanalsowashoffduringthesurgical
procedure allowing potential bacterial re-growth. There-
fore the use of plastic adhesive drapes were introduced
to prevent the direct exposure with the skin in which re-
maining or regenerating skin bacteria could be carried
into the surgical wound. Another option would be the use
of adhesive drapes impregnated with iodophor to allow
a continuously application of iodine, to reduce potential
bacterial re-growth. As some of the patients suffer from
iodine-allergy, the used of these drapes are, however
sometimes contra-indicated.
In a bacteriological study of Fairclough et al. [22], were
two groups of patients with (n=122) or without (n=107)
iodophorimpregnatedplasticadhesivedrapescompared.
The results of this study showed a 10- fold decrease of
SSIsinthegroupusingthisiodophorimpregnatedplastic
adhesive drapes. Yoshimura et al. [23] showed in a
similar study by 296 patients, that there was evidence
for using plastic adhesive drapes during surgery for pre-
venting superficial surgical site infections. Wound infec-
tion was significantly less likely with the use of iodophor
adhesivedrapes(3.1%)thanforsurgerywithoutiodophor
drapes (12.1%) (p>0.02). However, the relation ship
between using iodophor impregnated plastic adhesive
drapes or not and the risk for SSI has not yet been ad-
equately studied [24], [25].
Antibiotic prophylaxis
The risk of developing a postoperative infection depends
on the bacterial count in the wound by the end of the
operation [24]. Recent treatment with antibiotics may
change the commensal flora which allows colonization
with more antibiotic-resistant bacteria [26]. In these cir-
cumstances it maid be wise to delay elective surgical
procedures,ifthepatientisonorhasjustfinishedantibi-
otic treatment.
With antibiotic prophylaxis, the threshold for developing
infectionwasdecreased,buttheriskstilldependsonthe
degree of bacterial wound contamination [27].
Prophylactic intravenous antibiotics should be routinely
administered to patients undergoing cardiac surgery. In
other surgical specialties, there seems to be little debate
regarding prophylactic antibiotic duration. However, in
cardiac surgery there are several factors contribute to
the divergence of practice patterns:
• optimum duration has not been adequately explored
with identical antibiotics
• SSIs have been low during the years
• there has been only a vaguely perceived downside to
aggressive, prolonged prophylaxis.
Today there is a mounting evidence of important disad-
vantages to prolonged prophylaxis. Emerging antibiotic
resistance which seems to be an important issue is 1)
real, 2) clinically important, and 3) directly linked to the
duration of prophylactic antibiotic administration.
Harbarth et al. [28] showed in a trial of 2641 patients
undergoing coronary bypass surgery, that antibiotic pro-
phylaxis in patients receiving more than 48 hours have
an increased risk of antimicrobial resistance.
For the issue single versus multiple dose antibiotic pro-
phylaxis there is not yet a final statement possible due
tothelackofinconclusivedata.DiPiroetal.[29]reviewed
the literature about single-dose antibiotic in surgery and
concluded“thevalueofsingle-doseregimensduringopen
heart surgery has not yet been established”.
The first few hours following bacterial contamination
constitute a decisive period during which infection may
be established [30]. The effects of antibiotic administra-
tion are especially important during this period of time.
Antibiotics are effective when given within 3 hours of
bacterialinoculationbutareineffectivewhengivenmore
than 3 hours after inoculation [31], [32].
Intraoperative management
Another strategy to reduce SSIs is to improve the general
intraoperative condition of the patient, supporting the
natural host defense to eliminate bacteria.
Optimal temperature
Generalanesthesiaprofoundlyimpairsthermoregulatory
controlandnearlyallunwarmedsurgicalpatientsbecome
hypothermic.Thisresultsinashiftfromcore-to-peripheral
distributionofthecoretemperature[33].Evenmildhypo-
thermia can lead to severe complications including SSIs.
Hypothermiamayfacilitateperioperativewoundinfection
intwoways.First,sufficientintraoperativelyhypothermia
triggers thermoregulatory vasoconstriction [34] and the
risk of wound infection correlates with subcutaneous
oxygen tension [35]. Secondary, mild core hypothermia
directlyimpairsimmunefunctionincludingT-cell-mediated
antibody production [36] and “non-specific” oxidative
bacterial killing by neutrophils [37].
Kurz et al. [38] showed in randomized study that the
surgicalsiteinfectionratewastripledifthecoretempera-
ture was decreased 1.9°C from 36.5°C (n=104) to
34.5°C (n=96). The SSI rate in both groups was respect-
ively 5.8% versus 18.8% (p<0.009). Another issue in this
study was the fact, that patients were oxygenated three
hourslongercomparedtothepatientswhichwerenormo-
thermic monitored. During cardiopulmonary bypass, this
problem is minimal, however after surgery the core tem-
perature can drop, resulting in a prolonged oxygenation.
Inoff-pump,cardiacsurgery,absenceofcardiopulmonary
bypass use, this issue is a much more prominent.
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Diabetic patients have a two-to-three times increased
risk for SSI compared with non-diabetic patients after
cardiac surgery [39]. Furnary et al. [40] demonstrated a
significant reduction in deep sternal wound infections
when perioperative insulin management was switched
fromsubcutaneoustocontinuousinsulininfusion.Inthis
prospective study 2467 consecutive diabetic patients
were included undergoing cardiac surgery. There were
no differences in both groups according patient charac-
teristics. The deep sternal SSI could be significantly de-
creased (p<0.01) compared to the patients which re-
ceived insulin intermittent subcutaneously. This can be
explainedbythedeleteriouseffectofahyperglycemiaon
macrophage or neutrophil function [41].
Doenst et al. [42] performed a study on in total 6280
patient, diabetic (n=1579) and non-diabetic (n=4701),
who underwent cardiac surgery and insulin was given if
the glucose levels exceeded 15 mmol/L. There results
showed that closely control of the intraoperatively gly-
cemianotonlydecreasetheoperativemortalityindiabetic
but also in non-diabetic patients.
Hyperglycemiawasanindependentpredictorofmortality
in patients with diabetics (Odds ratio 1.20 (p=0.0005))
and all adverse events, including SSIs (Odds ratio 1.04
(p=0.0378)).Asimilarresultswasachievedinnon-diabet-
icpatients(Oddsratio1.20(p=0.0005))fortheoperative
mortality and all adverse events, including SSIs (Odds
ratio 1.04 (p=0.0378)).
Based on these studies it seems that hyperglycemia per
se increases the risk for SSIs and wound infection can
not be explained by the changes of the micro-circulation
of patients suffering from diabetic for many years [43].
Optimal oxygenation
The most important immune defense against surgical
pathogens are neutrophils, mediated by oxidative killing
and dependent on the production of bactericidal super-
oxide radicals from molecular oxygen [44]. The rate of
reaction,catalyzedbyNADPH-linkedoxygenase,isdepen-
dent on the partial pressure of tissue oxygen [45]. The
surgical incision will disrupt the local vascular supply,
which cause hypoxia of a wound compared with normal
tissue[46].Thereforeneutrophilsactivitydependsonthe
partialpressureofoxygen[35].Basedonthisbackground
information, Grief et al. [45] performed a randomized
double-blind study in patients undergoing colorectal re-
section.Supplemental30or80%inspiredoxygenshowed
a significant decrease of surgical-wound infections
(p=0.01), respectively 13/250 patients or 5.2% and
28/250 patients or 11.2%.
Belda et al. [47] showed similar results by performing
supplementaryoxygeninarandomizedstudyonpatients
undergoing colon surgery. Surgical wound infections oc-
curred in 24.4% of patients receiving 30% oxygen,
whether14.9%ofthosereceiving80%oxygen.Therewas
a statistical significant decrease found in this study
(p=0.04).
Hypoxiadoesnotonlyinduceperipheralvasoconstriction,
which decrease the blood supply into the wound but also
provokes pulmonary expression of inflammatory cyto-
kines. Furthermore oxygen partial pressure in wounds
regulates angiogenesis.
Velazquez [48] demonstrated in the mice model the im-
pact of angiogenesis and vasculogenesis in the wound
healinginischemicanddiabetic.Thenormalbloodsupply
improved wound healing due to the optimal delivery of
oxygen,nutrients,growthfactorsandprogenitorcellsand
removing the waste products.
In summary
Although we have a number of preoperative skin care
strategies (e.g. preoperative antiseptic showering, hair
removal, antisepsis of the patient skin, adhesive barrier
drapes and antimicrobial prophylaxis) to reduce the risk
forcontaminationbyendogenousskinfloraatthesurgical
site and optimized protocols as general intraoperatively
condition (e.g. optimal core temperature, optimal gly-
cemia,andoptimaloxygensupply)tosupportthenatural
host defense to eliminate bacteria new tools will be
needed to neutralize patient’s increased risk factors for
wound infections.
New preoperative skin care
strategies - pilot study with
InteguSeal®
Introduction
To decrease the contamination by the endogenous skin
flora, a microbial sealant, InteguSeal
®, (Kimberly Clark
Health Care, Atlanta, Georgia, USA) was recently intro-
duced. The advantage of InteguSeal
®, a n-butyl cyanoac-
rylate, intends to be applied on the skin over the com-
monly used surgical skin preparation. Upon contact with
the pre-operative antiseptic treated skin, InteguSeal
®
bonds to the skin and immobilize the bacteria. Naturally
and gradually InteguSeal
® will wears off the skin, as skin
exfoliates will started after three to seven days. We star-
tedapilotstudytoseetheeffectofthismicrobialsealant
in patient undergoing cardiac surgery.
Method
The total number of patients available, starting from
February 2007 till July 2007, for this analysis were 350
patients, namely 60 with InteguSeal
® and 290 patients
without InteguSeal
®. Data were grouped into patient
characteristics, operative data, postoperative data and
complications. The risk scoring system of Fowler et al.
[49]wasusingtoidentifythepreoperativeandcombined
infection risk scores for major infection in both groups.
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Data were analyzed using SPSS software (version 13.0;
SPSS, Inc., Chicago, IL). Categorical variables were ana-
lyzed using Chi-square. Continuous variables were ana-
lyzed with Student’s t test. P-value of less than .05 was
considered to be significant on two-tailed testing.
Results
The preoperative patient’s characteristics (risk factors)
of both groups were comparable in both groups in all
variables, except the following: The patients treated with
InteguSeal
® showed a highly significant rate of lower
ejection fraction (p=0.002), congestive heart failure
(p=0.001) and acute myocardial infarction (p=0.008)
compared with the control group.
The group of patients treated with InteguSeal
® showed a
highlysignificantnumberofpatientsundergoingconcomi-
tantprocedures(p=0.001),emergentsurgery(p=0.001),
whether the control group showed a significant higher
rate of patients with cardiopulmonary bypass time
between 100-200 minutes (0.001), increase number of
distal anastomoses (p=0.04) and elective operated
(p=0.003).
The clinical endpoint showed that in the group treated
with InteguSeal
® one patient suffered from surgical site
infection(1.7%),whetherthecontrolgroupshowedeleven
patients with a surgical site infection (3.8%), which was
not statistically significant (p=0.41). However the risk
scoring system of Fowler showed a statistical significant
difference between the risk factors of the InteguSeal
®
group and the control group. The predicted surgical site
infection due to the pre-operative risk factors was 3.1%
(score: 9.7±3.9%) versus 2.3% (score: 7.4±3.0%)
(p<0.001).Thepredictedsurgicalsiteinfectionbasedon
the intra-operative risk factors was 2.3% (score:
7.8±3.3%) versus 1.9% (score: 6.2±3.1%) (p<0.001).
Two of the eight patients suffering from SSI in the control
group died because of sepsis.
Conclusion
There is no question about the fact that a surgical site
infection is a major complication among cardiac surgery.
ThereisnogoldenregimetoexcludeSSIs,howeverthere
are guidelines on preoperative skin care measures to
reduce bacterial wound site contamination include pre-
operative antiseptic showering, hair removal, antisepsis
of the patient’s skin, adhesive barrier drapes, and antibi-
otic prophylaxis. The natural host defense to eliminate
bacteria of the patients needs to be optimal to support
the patient’s intraoperatively condition include core
temperature, glycemia, and oxygen supply .
Nevertheless we still have SSIs and therefore new
strategiestodecreasethecontaminationbytheendogen-
ous skin flora need to be evaluated. We started the use
ofamicrobialsealant,calledInteguSeal
®,toevaluatethe
additional impact of this new tool on SSIs. First clinical
resultswerepromising,althoughtherewerenostatistical
significance seen compared with the control group.
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